Related Experiment Video
Updated: Apr 23, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.2K
Resistance evolution in HIV - modeling when to intervene
Liliana Mabel Peinado Cortes1, Ryan Zurakowski2
1Biomedical Engineering Department at the National University of Columbia lilianamabel@gmail.com.
Summary
New HIV treatment strategies can significantly extend drug effectiveness. Targeting pre-existing resistance and improving patient compliance may add over 11 years to treatment longevity, improving patient and public health.
Area of Science:
- * Infectious Diseases
- * Mathematical Modeling
- * Public Health
Background:
- * Antiviral drug resistance and limited regimen options complicate Human Immunodeficiency Virus (HIV) treatment.
- * Sequential virological failures pose significant risks to patients, necessitating strategies to minimize their occurrence.
- * Understanding and predicting virological failure patterns is crucial for optimizing HIV management.
Purpose of the Study:
- * To introduce a Markov chain-based model for analyzing sequential virological failure in HIV.
- * To evaluate the impact of resistance-targeted interventions on treatment regimen longevity.
- * To assess the combined effect of resistance targeting and compliance interventions.
Main Methods:
- * Development of a Markov chain model to simulate sequential virological failure events.
- * Differentiating between various modes of virological failure within the model.
- * Simulation of a viral load preconditioning strategy to assess its impact on treatment longevity.
Main Results:
- * A resistance-targeted intervention demonstrated a potential increase of 3.3 years in the time to three sequential virological failures.
- * Combining resistance targeting with a patient compliance intervention showed a potential increase of up to 11.2 years.
- * The model provides a quantitative framework for evaluating intervention strategies.
Conclusions:
- * Targeted interventions, particularly those addressing pre-existing resistance and patient compliance, can significantly enhance HIV treatment durability.
- * Mathematical modeling offers a valuable tool for predicting the effectiveness of interventions in managing complex diseases like HIV.
- * Optimizing HIV treatment strategies has substantial implications for individual patient outcomes and broader public health.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
42.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
Viral Mutations
32.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.6K

